BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2017.
World J Gastroenterol. Sep 14, 2017; 23(34): 6294-6305
Published online Sep 14, 2017. doi: 10.3748/wjg.v23.i34.6294
Table 4 Number of Crohn’s disease patients and the use of biologicals
CountryEstimated number of CD patients/sourceNumber of patients on biologicals1/sourcePatients on biologicals per 100000 population (calculated)Patients on biologicals per 1000 patients (calculated)
Cz8768Rencz et al[3], 2015 (based on estimation)990Rencz et al[3], 20159.4112.9
Fr72522Kirchgesner et al[28], 2017 (administrative database)22671Estimation based on Kirchgesner et al[28], 201734.0312.6
D180000Estimate by the collaborating expert based on CD incidence and prevalence in two regional cohort studies from the 90ties.27000Estimation (based on the estimated % of patients on biologicals and the total number of CD patients)32.9150.0
Hu9775Rencz et al[3], 2015 (based on epidemiology study)1870Rencz et al[3], 201519.0191.3
Lv1695Rencz et al[3], 2015 (based on estimation)3Rencz et al[3], 20150.21.8
Pl32049Rencz et al[3], 2015 (based on estimation)888Rencz et al[3], 20152.327.7
Ro11000Estimate for 2016 by the collaborating expert based on National database including 13 IBD centers253Rencz et al[3], 20151.323.0
Sk3687Rencz et al[3], 2015 (epidemiology study)690Rencz et al[3], 201512.7187.1
Es60000Arin Letamendia et al[29], 2008 (prospective, population-based study)15000Estimation (based on the estimated % of patients on biologicals from the ENEIDA database2 and the total number of CD patients)32.3250.0
Se34318SWIBREG3 combined with the Swedish National Patient Register5270SWIBREG3 combined with The Prescribed Drug Register53.5153.6


Write to the Help Desk